737 filings
Page 24 of 37
8-K
f4o2ko8zy6cfhhxc
3 May 10
Adventrx Pharmaceuticals Announces Financing
12:00am
424B5
xs1hj3x27718rc7i
3 May 10
Prospectus supplement for primary offering
12:00am
8-K
fbkireeg85x0v jx
3 May 10
Adventrx Announces 6-MONTH Stability Data Results for ANX-530
12:00am
424B3
yj9l2ihtunme
3 May 10
Prospectus supplement
12:00am
8-K
tpql8x4tacg
30 Apr 10
Adventrx Reports First Quarter Financial Results
12:00am
8-K
0umh z7ze
27 Apr 10
Adventrx to Resubmit ANX-530 Nda In the Fourth Quarter of 2010
12:00am
424B3
qpu5jxd 0qe3p48d
27 Apr 10
Prospectus supplement
12:00am
8-K
2xn jtaxbdi61j
26 Apr 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
tvm31 br5lc1s3m
16 Apr 10
Results of Operations and Financial Condition
12:00am
EFFECT
2brw69a
1 Apr 10
Notice of effectiveness
12:00am
EFFECT
83xndslm7
23 Mar 10
Notice of effectiveness
12:00am
POS AM
fhoiskharv2e
18 Mar 10
Prospectus update (post-effective amendment)
12:00am
8-K
pvnywhxaxfb6
16 Mar 10
Adventrx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
12:00am
424B3
q7wunlthshfu19xxbw4t
1 Mar 10
Prospectus supplement
12:00am
8-K
5vnxlw0xuc9nq
1 Mar 10
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
12:00am
424B3
m9ogyw6
11 Feb 10
Prospectus supplement
12:00am